VaccinesTrial: HVTN 084
Phase: I
Start Date: February 2011
Sponsor, funder, developer: DAIDS, HVTN, VRC
Vaccine(s): rAd5:(VRC-HIVADV014-00-VP); rAd5:(VRC-HIVADV054-00-VP)
Inserts: ADV014:clade B gag-pol; clades A, B, C env; ADV054: clade B gag-pol
Clade: A, B, C
Trial: HVTN 078
Phase: I/II
Start Date: October 2009
Sponsor, funder, developer: NIAID, EuroVacc, HVTN
Total participants: 80
Vaccine(s): NYVAC-B; VRC-HIVADV038-00-VP
Clade: A, B, C
* WHO, UNAIDS, and UNICEF. Epidemiological Fact Sheet on HIV and AIDS: Core data on epidemiological and response Switzerland 2008 Update. 2008. http://apps.who.int/globalatlas/predefinedReports/EFS2008/full/EFS2008_CH.pdf